medigraphic.com
ISSN 0001-0944 (Print)
Órgano Oficial de la Asociación Dental Mexicana

2022, Number 2

<< Back Next >>

Rev ADM 2022; 79 (2)

Taste and olfactory dysfunction in a context of SARS-CoV-2 infection prediction.

Mendoza GSM, Zepeda RKI, Gallardo LCA, Pérez MIO

Language: Spanish
References: 29
Page: 92-96
PDF size: 198.73 Kb.


ABSTRACT

The timely identification of the signs and symptoms produced by the SARS-CoV-2 infection (COVID-19) is essential in medical and dental care; the detection of the condition must be timely and, if possible, anticipated to the application of tests definitive for diagnosis. The exhaustive search for strategies for this timely detection has led many researchers and scientists to determine the relevant symptoms, including taste and olfactory alterations, with a high degree of prediction. This review aims to show evidence of these alterations and their vital predictive element to promptly detect COVID-19 in the medical or dental office and clinical studies in the Mexican population.


REFERENCES

  1. Carpenter CR, Mudd PA, West CP, Wilber E, Wilber ST. Diagnosing COVID-19 in the emergency department: a scoping review of clinical examinations, laboratory tests, imaging accuracy, and biases. Acad Emerg Med. 2020; 27 (8): 653-670.

  2. Chow YP, Chin BHZ, Loo JM, Moorthy LR, Jairaman J, Tan LH et al. Clinical and epidemiological characteristics of patients seeking COVID-19 testing in a private centre in Malaysia: Is there a role for private healthcare in battling the outbreak? PLoS One. 2021; 16 (10): e0258671.

  3. Menni C, Valdes AM, Freidin MB, Sudre CH, Nguyen LH, Drew DA et al. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med. 2020; 26 (7): 1037-1040.

  4. Bidkar V, Mishra M, Selvaraj K, Joshi P, H SB, Dabhekar S et al. Testing olfactory and gustatory dysfunctions among quarantine COVID-19 suspects. Indian J Otolaryngol Head Neck Surg. 2021; 73 (3): 304-309.

  5. Callejon-Leblic MA, Moreno-Luna R, Del Cuvillo A, Reyes-Tejero IM, Garcia-Villaran MA, Santos-Pena M et al. Loss of smell and taste can accurately predict COVID-19 infection: a machine-learning approach. J Clin Med. 2021; 10 (4): 570.

  6. Salmon CD, Bartier S, Hautefort C, Nguyen Y, Nevoux J, Hamel AL et al. Self-reported loss of smell without nasal obstruction to identify COVID-19. The multicenter coranosmia cohort study. J Infect. 2020; 81 (4): 614-620.

  7. Menezes AMB, Victora CG, Hartwig FP, Silveira MF, Horta BL, Barros AJD et al. High prevalence of symptoms among Brazilian subjects with antibodies against SARS-CoV-2. Sci Rep. 2021; 11 (1): 13279.

  8. Akinbami LJ, Petersen LR, Sami S, Vuong N, Lukacs SL, Mackey L et al. Coronavirus disease 2019 symptoms and severe acute respiratory syndrome coronavirus 2 antibody positivity in a large survey of first responders and healthcare personnel.2020. Clin Infect Dis. 2021; 73 (3): e822-e825.

  9. Schirinzi A, Cazzolla AP, Lovero R, Lo Muzio L, Testa NF, Ciavarella D et al. New insights in laboratory testing for COVID-19 patients: looking for the role and predictive value of human epididymis secretory protein 4 (HE4) and the innate immunity of the oral cavity and respiratory tract. Microorganisms. 2020; 8 (11): 1718.

  10. Perula de Torres LA, Gonzalez-Lama J, Jimenez GC, Sanchez Montero R, Rider Garrido F, Ortega Lopez Y et al. Frequency and predictive validity of olfactory and taste dysfunction in patients with SARS-CoV-2 infection. Med Clin (Barc). 2021; 156 (12): 595-601.

  11. Vaira LA, Hopkins C, Petrocelli M, Lechien JR, Soma D, Giovanditto F et al. Do olfactory and gustatory psychophysical scores have prognostic value in COVID-19 patients? A prospective study of 106 patients. J Otolaryngol Head Neck Surg. 2020; 49 (1): 56.

  12. Nuertey BD, Ekremet K, Haidallah AR, Mumuni K, Addai J, Attibu RIE et al. Performance of COVID-19 associated symptoms and temperature checking as a screening tool for SARS-CoV-2 infection. PLoS One. 2021; 16 (9): e0257450.

  13. Guemes A, Ray S, Aboumerhi K, Desjardins MR, Kvit A, Corrigan AE et al. A syndromic surveillance tool to detect anomalous clusters of COVID-19 symptoms in the United States. Sci Rep. 2021; 11 (1): 4660.

  14. Smith DS, Richey EA, Brunetto WL. A Symptom-based rule for diagnosis of COVID-19. SN Compr Clin Med. 2020; 2 (11): 1947-1954.

  15. Roland LT, Gurrola JG 2nd, Loftus PA, Cheung SW, Chang JL. Smell and taste symptom-based predictive model for COVID-19 diagnosis. Int Forum Allergy Rhinol. 2020; 10 (7): 832-838.

  16. Seale H, Heywood AE, Leask J, Sheel M, Thomas S, Durrheim DN et al. COVID-19 is rapidly changing: Examining public perceptions and behaviors in response to this evolving pandemic. PLoS One. 2020; 15 (6): e0235112.

  17. Zens M, Brammertz A, Herpich J, Sudkamp N, Hinterseer M. App-based tracking of self-reported COVID-19 symptoms: analysis of questionnaire data. J Med Internet Res. 2020; 22 (9): e21956.

  18. Haehner A, Draf J, Drager S, de With K, Hummel T. Predictive value of sudden olfactory loss in the diagnosis of COVID-19. ORL J Otorhinolaryngol Relat Spec. 2020; 82 (4): 175-180.

  19. Rocke J, Hopkins C, Philpott C, Kumar N. Is loss of sense of smell a diagnostic marker in COVID-19: a systematic review and meta-analysis. Clin Otolaryngol. 2020; 45 (6): 914-922.

  20. Kavaz E, Tahir E, Kurnaz SC, Deveci A, Tanyel EA. Clinical, prognostic, and predictive value of olfactory dysfunction for COVID-19: a prospective controlled study. Otolaryngol Head Neck Surg. 2021: 1945998211057024.

  21. Gerkin RC, Ohla K, Veldhuizen MG, Joseph PV, Kelly CE, Bakke AJ et al. Recent smell loss is the best predictor of COVID-19 among individuals with recent respiratory symptoms. Chem Senses. 2021; 46: bjaa081.

  22. Rouadi PW, Idriss SA, Bousquet J. Olfactory and taste dysfunctions in COVID-19. Curr Opin Allergy Clin Immunol. 2021; 21 (3): 229-244.

  23. Iravani B, Arshamian A, Ravia A, Mishor E, Snitz K, Shushan S et al. Relationship between odor intensity estimates and COVID-19 prevalence prediction in a Swedish population. Chem Senses. 2020; bjaa034.

  24. Printza A, Katotomichelakis M, Valsamidis K, Metallidis S, Panagopoulos P, Panopoulou M et al. Smell and taste loss recovery time in COVID-19 patients and disease severity. J Clin Med. 2021; 10 (5): 966.

  25. Kopishinskaia S, Lapshova D, Sherman M, Velichko I, Voznesensky N, Voznesenskaia VJPD. Clinical features in russian patients with COVID-associated parosmia/phanthosmia. Psychiatr Danub. 2021; 33 (Suppl 9): 130-136.

  26. Doyle ME, Appleton A, Liu QR, Yao Q, Mazucanti CH, Egan JM. Human type II taste cells express angiotensin-converting enzyme 2 and are infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Am J Pathol. 2021; 191 (9): 1511-1519.

  27. Hannum ME, Koch RJ, Ramirez VA, Marks SS, Toskala AK, Herriman RD et al. Taste loss as a distinct symptom of COVID-19: a systematic review and meta-analysis. medRxiv. 2021.

  28. Sahni V. Are there any significant craniomaxillofacial manifestations of COVID-19? Evid Based Dent. 2021; 22 (2): 72-73.

  29. Cirillo N. Taste alteration in COVID-19: Significant geographical differences exist in the prevalence of the symptom. J Infect Public Health. 2021; 14 (8): 1099-1105.




2020     |     www.medigraphic.com